Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Walker: bNabs after Infection and Immunization |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Human |
| Stage: | Assays Completed |
| Study Start Date: | 2014-02-14 |
| Study Made Public: | 2016-03-14 |
Title
Screening for Neutralizing Antibody Breadth #2
Description
CAVD 441 is an immunogenicity study evaluating neutralizing antibody breadth in plasma from HIV-infected participants.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.